Company Overview and News

 
Hathway Cable, DEN Network, GTPL Hathway jump up to 20% on RIL stake buy buzz

3m moneycontrol
Share price of Hathway Cable and DEN Network gained up to 7 percent intraday Tuesday on news Reliance Industries is likely to buy controlling stake in both the companies.
DEN 500325 RELIANCE RIGD 533137 RLNIY

 
Hathway, DEN Networks rally 8% as RIL eyes controlling stake

50m thehindubusinessline
Shares of cable TV and broadband service providers Hathway Cable & Datacom and DEN Networks Ltd jumped 8.16 per cent and 7.82 per cent, respectively.
DEN SOUTHBANK 500325 RELIANCE RIGD 532218 533137 RLNIY

 
Amid Mukesh Ambani-led Reliance Industries’ stake buy reports, shares of Hathway, DEN up nearly 8%

50m financialexpress
The shares of Hathway Cable and DEN Networks surged nearly 8 percent from the previous close in intraday trade on BSE amid media reports that Mukesh Ambani’s Reliance Industries (RIL) may takeover controlling stakes in the country’s largest cable TV and broadband service providers.
DEN 500325 RELIANCE RIGD 533137 RLNIY

 
RIL buying controlling stake in Hathway Den Networks is a #39;win-win deal#39;: Edelweiss

1h moneycontrol
Reliance Industries Ltd (RIL) is likely to announce a deal on Wednesday to buy a controlling stake in Hathway and Den Networks.
DEN 500325 RELIANCE RIGD 533137 RLNIY

 
Earnings will dictate trend for market this week; Lupin, Tata Global top buy ideas

1h moneycontrol
The Indian market managed to end with modest gains last week amid excessive volatility. Weakening rupee combined with a surge in the crude oil prices continue to weigh on the market sentiment.
500182 500325 RELIANCE RIGD HEROMOTOCO HRTQY RLNIY

 
Fuel price control lowers confidence of investments in India, say BP chief

15h thehindubusinessline
The Centre’s move to direct oil marketing companies to lower auto fuel price hampers the confidence of oil companies in investments make in India, according to BP.
500325 RELIANCE RIGD RLNIY

 
Revealed! Why British Petroleum curtailed investments in India in past

17h financialexpress
High natural gas prices in India made British Petroleum (BP) curtail investment in the country, ET Now reported citing company CEO Bob Dudley. However, India is an important market for the oil major and the firm is in talks with Reliance Industries Limited (RIL) to venture into downstream business, Bob Dudley told ET Now on the sidelines of an event. On rising crude prices worldwide, BP CEO said the oil prices are very high particularly in India and Turkey.
500325 RELIANCE RIGD RLNIY

 
India has optional volumes from Saudi, others to make up for shortfall from Iran: Officials

2018-10-15 financialexpress
Indian oil companies like IOC have optional volumes built in their annual crude oil purchase contracts with suppliers like Saudi Arabia and Iraq that will be more than enough to make up for any shortfall in supplies from sanctions-hit Iran, senior officials said Monday.
IOC 500325 500116 RELIANCE RIGD IDBI 500134 ESSAROIL 532505 530965 UCOBANK RLNIY

 
India has optional volumes from Saudi Arabia, others to make up for shortfall from Iran

2018-10-15 moneycontrol
Indian oil companies like IOC have optional volumes built in their annual crude oil purchase contracts with suppliers like Saudi Arabia and Iraq that will be more than enough to make up for any shortfall in supplies from sanctions-hit Iran, senior officials said Monday.
IOC 500325 500116 RELIANCE RIGD IDBI 500134 ESSAROIL 532505 530965 UCOBANK RLNIY

 
D-Street Buzz: Nifty IT, pharma outperforms led by KPIT Tech, Dr Reddy#39;s Labs; auto drags

2018-10-15 moneycontrol
The Indian benchmark indices are trading in the red this Monday morning with the Nifty50 down 25 points, trading at 10,446 while the Sensex shed 47 points at 34,685.
IOC BAJAJ-AUTO 500408 500325 524816 RELIANCE TCHQY 532218 532977 532755 CADILAHC 535789 505200 SOUTHBANK 532343 532321 NATCOPHARM PINCON RIGD GAILF EICHERMOT RLNIY ECQRY 538771 TVSMOTOR IDKQY 530965 CDLYY TECHM IBULHSGFIN GAILY TATAELXSI DCMSHRIRAM 523367

 
Current tarrifs not sustainable, expect three more quarters of losses for telecom industry: COAI’s Rajan Mathews

2018-10-14 financialexpress
The telecom sector is likely to experience three more quarters of losses, hurt by high levies and “unsustainable tariffs”, a top official of industry body COAI has said. “Under the current scenario, I see at least another three plus quarters of losses. Why? Because personally, I do not think the present tariffs are sustainable for long term health of the industry…,” COAI Director General, Rajan Mathews told PTI.
532454 500325 RELIANCE RIGD IDEA ICLQY 532822 BHRQY BHARTIARTL RLNIY

1
Three of top-10 firms lose Rs 1 lakh cr in m-cap; TCS hit hard

2018-10-14 thehindubusinessline
Three of the 10 most valued Indian companies together witnessed an erosion of Rs 1,07,026.12 crore in market capitalisation last week, with IT major Tata Consultancy Services (TCS) taking the biggest knock.
500325 KMBKY RELIANCE HINDUNILVR TTNQY MRZUY 532500 532540 HDB MARUTI 500180 RIGD KOTAKBANK 500696 HDFCBANK TCS 500247 RLNIY SBAZ

1
Three of top-10 cos lose Rs 1 lakh crore in m-cap; TCS takes biggest knock of Rs 85,330.17 crore

2018-10-14 financialexpress
Three of the 10 most valued Indian companies together witnessed an erosion of Rs 1,07,026.12 crore in market capitalisation last week, with IT major TCS taking the biggest knock. Tata Consultancy Services (TCS), ITC and Infosys suffered a decline in their valuation for the week ended Friday, whereas RIL, HDFC Bank, Hindustan Unilever Ltd (HUL), HDFC, SBI, Kotak Mahindra Bank and Maruti Suzuki India finished with gains.
500325 KMBKY RELIANCE HINDUNILVR TTNQY MRZUY 532500 532540 HDB MARUTI 500180 RIGD KOTAKBANK 500696 HDFCBANK TCS 500247 RLNIY SBAZ

5
Stock market weekly wrap: Sensex, Nifty snap 5 straight weeks of losses; Q2 results may chart course ahead

2018-10-13 financialexpress
Snapping a five-week losing streak, Sensex and Nifty made a comeback — gaining up to 1.5% — despite bears ruling the domestic equity markets for three out of five trading sessions during the week amid huge volatility. A respite came in the form of easing crude oil prices, a recovery in the rupee from record lows and value buying in banking, oil marketing companies and auto stocks.
500325 RELIANCE 532538 532187 RIGD UCLQY HDFCBANK HEROMOTOCO 500570 TATAMOTORS RLNIY YESBANK INDUSINDBK KMBKY UCLQF 532648 YYBKY ULTRACEMCO 500182 HDB 500180 KOTAKBANK HRTQY 500247 TTM

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...